AI assistant
Sending…
NEOGEN CORP — Director's Dealing 2025
Oct 27, 2025
32081_dirs_2025-10-27_c7038e07-2e6f-43e4-8995-31672a7a7682.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGEN CORP (NEOG)
CIK: 0000711377
Period of Report: 2025-10-23
Reporting Person: Woteki Catherine E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-23 | Common Stock | A | 19769 | $6.07 | Acquired | 35084 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-23 | Common Stock (Right to Buy) | $6.07 | A | 50814 | Acquired | 2035-10-23 | Common Stock (50814) | Direct |
Footnotes
F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
More from NEOGEN CORP
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 20
Interim / Quarterly Report
2026
Apr 9
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17